.After antibody-drug conjugate (ADC) specialist Seagen was actually offered to Pfizer last year for ...
.On the heels of a phase 3 gain that failed to make an impression on clients, Ironwood Pharmaceutica...
.Do not quit Monte Rosa Rehabs now. The Boston-based biotech is enjoying after signing a handle Nova...
.Invite to today's Chutes & Ladders, our summary of significant leadership hirings, shootings and...
.Celebrating his provider's upsized going public (IPO), Septerna chief executive officer Jeffrey Fin...
.AbbVie has actually returned to the source of its own antipsychotic powerhouse Vraylar seeking an a...
.GenSight Biologics is weeks out of running out of amount of money. Once more. The biotech simply po...
.Monopar Rehabs is actually recouping a medicine coming from the scrap heap of AstraZeneca's unusual...
.With new records out on Arcus Biosciences' experimental HIF-2a prevention, one team of analysts wor...
.After forming a gene treatment relationship with Dyno Rehabs in 2020, Roche is back for more.In a b...